ACT Venture Partners
ACT Venture Partners news

Driving Progress: Key 2024 Updates from ACT Venture Partners

In 2024, we continued expanding our portfolio with investments in Qubitrium, Meddenovo Drug Design,Nextmol, and Rototip—startups at the forefront of innovation in sectors like quantum computing, AI, biotechnology, sustainable materials, and digital manufacturing. These strategic investments align with our deep-tech focus, reinforcing our mission to back pioneers shaping the future. To dive deeper into each of these exciting stories, visit our dedicated page: ACT Venture Partners Stories.
Article content
Highlight: Picus Security's Major Funding Round
We are excited to share that Picus Security, one of our portfolio stars, has raised $45 million Series C led by Riverwood Capital. This marks a significant milestone in their journey to redefine cybersecurity, and we are proud to have led their Series Seed round. With this growth round, Picus is poised to drive even more innovation in adversarial exposure validation and continue its leadership in the cybersecurity space.
Article content
Huge congratulations to the entire team for their dedication and hard work! Excited to see what’s next in this journey. 🚀
Prof. Sanyal’s Recognition as a European Women Innovator Prize Winner
RS Research continues to make significant advances in both science and leadership. Prof. Rana Sanyal, the co-founder of RS Research, was honored with the prestigious European Women Innovator Prize in 2024, recognizing her outstanding contributions to innovation and entrepreneurship in oncology. Following this recognition, Prof. Sanyal has participated in key European events, such as the ERA Conference 2024, where she inspires women in science and business with her journey and achievements.
Prof. Sanyal with EU Commissioner for Research and Innovation
Prof. Sanyal with EU Commissioner for Research and Innovation
RS Research is progressing with its Phase 1 clinical trials in Türkiye, making important headway in oncology treatments. The Turkish Minister of Health acknowledged the company’s accomplishments and supported their pioneering work. RS Research continues to lead the development of cancer therapies, while Prof. Sanyal’s recognition amplifies the impact of women in innovation and entrepreneurship.
Portfolio Updates
  • Eatron Technologies: Eatron has had a dynamic year, securing double-digit million USD funding in their Series A2 round, with new investors like LG Technology Ventures and Oshkosh Corporation. In June 2024, they launched a groundbreaking AI-powered Battery Management System on Chip,developed in collaboration with Syntiant. This innovative solution is set to revolutionize battery management across industries.
  • Aibuild: Aibuild launched Aibuild 2.0, a major milestone in their journey to becoming the leading central hub for manufacturing. The new version brings cutting-edge features that streamline manufacturing processes and improve efficiency. They have also been highly visible in events like RAPID + TCT, continuing to build strong connections with partners and industry leaders in North America.
  • Productive Machines: Productive Machines recently launched SenseNC Finesse, an advanced automated CNC optimization software designed to deliver optimum toolpaths, feeds, and speeds for both complex and simple parts. The team also shared a compelling case study with AML Sheffield, showcasing their commitment to improving CNC machining processes and helping manufacturers reduce costs while enhancing precision.